Mortality and clinical outcomes of ceftazidime/avibactam vs best available therapy in treating carbapenem-resistant enterobacterales infections: A retrospective cohort study

Objective: The epidemiology of infectious diseases shows that antimicrobial resistance (AMR) is a global health issue. This study aimed to compare 14-day mortality in patients with confirmed Carbapenem-resistant Enterobacterales (CRE) infections treated with Ceftazidime/Avibactam (CAZ-AVI) to the be...

Full description

Saved in:
Bibliographic Details
Main Authors: Nada Alhamed, Mai Hashhoush, Raghad Al-Omari, Marwa Alomani, Reem S. AlOmar
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Clinical Epidemiology and Global Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213398425001502
Tags: Add Tag
No Tags, Be the first to tag this record!